Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anecortave Acetate in Open-Angle Glaucoma
NCT00451152Phase 2Completed
- Sponsor
- Alcon Inc.
- Start
- Mar 2007
- Primary completion
- Jul 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of anecortave in open-angle glaucoma (OAG), sponsored by Alcon Inc.. Started Mar 2007; status: completed.
02
Drugs
anecortave
03
Conditions
open-angle glaucoma (OAG)
Beyond the preview
Go deeper on NCT00451152.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00451152.